Richard R. DeLuca - Jan 22, 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP&Pres, Merck Animal Heallth
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Richard R. DeLuca, Jr.
Stock symbol
MRK
Transactions as of
Jan 22, 2024
Transactions value $
$2,782,241
Form type
4
Date filed
1/24/2024, 04:06 PM
Previous filing
Nov 9, 2023
Next filing
May 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Award $2.78M +23.3K +20.71% $119.43 136K Jan 22, 2024 Direct F1, F2
holding MRK Common Stock - 401(k) Plan 1.23K Jan 22, 2024 By 401(k) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/21. Performance shares were paid out at 161 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2023.
F2 Holdings include shares acquired in dividend reinvestment transactions.
F3 Includes shares acquired and dividends earned through January 8, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.